Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 829,448 | 3,551 | 240,735 | 243,231 | 138,287 |
| Gross Profit | 829,448 | 3,551 | 240,735 | 243,231 | 138,287 |
| Operating Expenses | 731,102 | 604,631 | 445,737 | 421,738 | 287,323 |
| Operating Income | 98,346 | -601,080 | -205,002 | -178,507 | -149,036 |
| Interest Expense | 89,361 | 32,352 | 18,326 | 0 | 0 |
| Other Income | 42,548 | 20,972 | 16,837 | 5,798 | 8,190 |
| Pre-tax Income | 51,533 | -612,460 | -206,491 | -172,709 | -140,846 |
| Income Tax | 21,419 | -2,767 | 2,784 | 3,785 | 2 |
| Net Income Continuous | 30,114 | -609,693 | -209,275 | -176,494 | -140,848 |
| Minority Interests | 31,745 | -10,200 | -4,000 | -431 | N/A |
| Net Income | $-1,631 | $-599,493 | $-205,275 | $-176,063 | $-140,848 |
| EPS Basic Total Ops | -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
| EPS Basic Continuous Ops | 0.23 | -5.09 | -1.96 | -1.67 | -1.36 |
| EPS Diluted Total Ops | -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
| EPS Diluted Continuous Ops | 0.23 | -5.09 | -1.96 | -1.67 | -1.36 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
| EBITDA(a) | $116,485 | $-585,729 | $-194,526 | $-165,176 | $-140,503 |